EUVIMEDEUVIMED entdecken
Crossref

KLF9 regulates osteogenic differentiation of mesenchymal stem cells

Xiaoxiao Xiao, Ming Zhang, Yiwei Qian, Xuepeng Wang, Qiang Wu

Journal of Molecular Histology · 2024

DOI: 10.1007/s10735-024-10204-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Histology, 2024. Verfasst von Xiaoxiao Xiao und 4 weiteren Autor:innen. Beteiligte Einrichtung: The State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Kruppel-Like Transcription Factors, Osteogenesis, Cell Differentiation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoporosis is a progressive skeletal disease which is characterized by reduced bone mass and degradation of bone microstructure. Mesenchymal stem cells (MSCs) have the potential to inhibit osteoporosis since they are multipotent stem cells that can differentiate into multiple types of cells including osteoblasts. Hence the mechanism of osteogenic differentiation of MSCs deserves comprehensive study. Here we report that KLF9 is a novel regulator in osteogenic differentiation of MSCs. We observed that depletion of KLF9 can largely compromise the osteogenic differentiation ability of MSCs. In addition, we revealed that inhibition of the PI3K-Akt pathway could also affect osteogenic differentiation since KLF9 depletion inhibits PI3K expression. Finally, we discovered that KLF9 expression can be induced by dexamethasone which is an essential component in osteogenic induction medium. Taken together, our study provides new insights into the regulatory role of KLF9 in osteogenic differentiation of MSCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsKruppel-Like Transcription FactorsOsteogenesisCell DifferentiationProto-Oncogene Proteins c-aktHumansPhosphatidylinositol 3-KinasesSignal TransductionDexamethasoneCells, Cultured

Stichwörter der Autor:innen

DexamethasoneKLF9MSCsOsteogenic differentiationPI3K-Akt pathway

Substanzen

Kruppel-Like Transcription FactorsKLF9 protein, humanProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesDexamethasone

Autor:innen und Institutionen

  • The State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.
  • Faculty of Chinese Medicine, Hunan Traditional Chinese Medical College, Zhuzhou, China.
  • Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • The State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China. qwu@must.edu.mo.

Zitieren

APA

Xiao, X., Zhang, M., Qian, Y., Wang, X., & Wu, Q. (2024). KLF9 regulates osteogenic differentiation of mesenchymal stem cells. Journal of Molecular Histology. https://doi.org/10.1007/s10735-024-10204-6

Vancouver

Xiao X, Zhang M, Qian Y, Wang X, Wu Q. KLF9 regulates osteogenic differentiation of mesenchymal stem cells. Journal of Molecular Histology. 2024. doi:10.1007/s10735-024-10204-6

BibTeX
@article{Xiao2024,
  author = {Xiao, Xiaoxiao and Zhang, Ming and Qian, Yiwei and Wang, Xuepeng and Wu, Qiang},
  title = {KLF9 regulates osteogenic differentiation of mesenchymal stem cells},
  journal = {Journal of Molecular Histology},
  year = {2024},
  doi = {10.1007/s10735-024-10204-6}
}
Kostenlos starten →